Guidance for Valeant Pharmaceuticals International (VRX)
| Period |
Range |
Estimate |
Revenue Range |
Revenue Estimate |
Target |
Details |
| 2013 |
$5.55 – 5.85 |
N/A |
$4.40B – 4.80B |
N/A |
 Raised |
Details |
| 2012 |
$4.45 – 4.70 |
N/A |
$3.40B – 3.60B |
N/A |
Raised |
Details |
| 2012 |
$4.55 – 4.75 |
$4.51 |
N/A |
N/A |
= Maintained |
Details |
| 2012 |
$4.60 – 4.65 |
N/A |
N/A |
N/A |
= Maintained |
Details |
| Q4 2012 |
$1.30 – 1.35 |
N/A |
N/A |
N/A |
= Maintained |
Details |
| 2011 |
$2.45 – 2.70 |
N/A |
N/A |
N/A |
= Maintained |
Details |
| 2011 |
$2.70 – 3.00 |
N/A |
N/A |
N/A |
Raised |
Details |
| 2011 |
$2.65 – 2.90 |
N/A |
N/A |
N/A |
= Maintained |
Details |
